Mylan Nifedipine XL Exclusivity Forfeited By Settling With Pfizer, Teva Says

Mylan's generic nifedipine extended-release tablets should no longer be eligible for 180-day exclusivity because of the company's patent litigation settlement with Pfizer, Teva told FDA in a citizen petition.